Metalloproteinase expression is associated with traumatic wound failure.

Area of Science:

• Biochemistry
• Wound Healing Research
• Biomarker Discovery

Background:

• Matrix metalloproteinases (MMPs) play vital roles in the inflammatory and remodeling stages of wound healing.
• Previous research established a link between pro-inflammatory cytokines and successful combat wound closure.
• This study investigates the relationship between MMP expression during wound remodeling and overall healing outcomes.

Purpose of the Study:

• To investigate the correlation between matrix metalloproteinase (MMP) expression during wound remodeling and the healing of traumatic combat wounds.
• To identify specific MMPs that can serve as predictive biomarkers for wound healing outcomes.
• To determine if MMP levels can provide objective evidence for guiding wound closure timing.

Main Methods:

• Prospective study of 38 wounds in 25 patients with combat-related extremity trauma.
• Repeated surgical debridement and vacuum-assisted closure (VAC) application every 48-72 hours until wound closure.
• Analysis of wound effluent and patient serum for five MMPs using Luminex multiplex system; MMP expression compared between impaired and normal healing wounds.

Main Results:

• Impaired healing wounds (n=9) showed elevated serum MMP-2 and MMP-7 levels and reduced effluent MMP-3 compared to normally healing wounds (n=29).
• Receiver operating characteristic (ROC) curve analysis demonstrated significant predictive value for these MMPs.
• Area under the curve (AUC) values ranged from 0.744 to 0.805, indicating strong discriminatory power.

Conclusions:

• Impaired wound healing in combat casualties is associated with specific pro-inflammatory MMP profiles, notably MMP-2 and MMP-7.
• Serum and effluent concentrations of MMP-2, MMP-3, and MMP-7 are effective predictors of traumatic war wound outcomes.
• MMP analysis offers potential for objective, decision-supportive evidence in determining optimal timing for wound closure.